Cancer pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with tumors confirmed by pathology or cytology; 2. Age >= 18 years; 3. Presence of cancer pain (NRS >= 4) and currently being treated with OxyContin (Oxycodone Hydrochloride Sustained-Release Tablets), or assessed as requiring initiation of OxyContin treatment; 4. Life expectancy >= 3 months; voluntary participation in this study and signing of the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Non-cancerous pain or pain of unknown cause; 2. Allergy to oxycodone or contraindications to opioids (e.g., severe respiratory depression, intestinal obstruction); 3. Use of non-OxyContin opioid analgesics (e.g., sustained-release morphine tablets, fentanyl patches) as the baseline analgesic regimen; 4. Severe dysfunction of vital organs such as the heart, lungs, liver, or kidneys; 5. Presence of mental illness or cognitive impairment that prevents cooperation with the study; 6. Current participation in other clinical studies that may affect the use of analgesic medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of reaching the standard for pain control;compliance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale (HADS); | — |
Countries
China
Contacts
Shanghai General Hospital